NewtekOne, Inc. - Common Stock (NEWT)
12.98
0.00 (0.00%)
NewtekOne Inc is a financial services company that provides a comprehensive range of solutions for small to medium-sized businesses
Through its various subsidiaries, the company offers lending programs, payment processing, and business advisory services, helping entrepreneurs achieve their growth and operational goals. By leveraging technology and innovative financial products, NewtekOne aims to empower businesses with the resources and support they need to succeed in a competitive marketplace. The company positions itself as a trusted partner, facilitating access to capital and a suite of services tailored to meet the unique needs of its clients.
![](https://cdn.benzinga.com/files/images/story/2024/09/19/Wall-Street.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 19, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
NEWT stock results show that NewtekOne beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/07/26/Dividends-Text-On-Documents-With-Graphs-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · July 26, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
NEWT stock results show that NewtekOne beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024
![](https://cdn.pixabay.com/photo/2016/11/27/21/42/stock-1863880_960_720.jpg)
The company's higher profit margins allow NEWT to have among the highest-yielding corporate business accounts and offer the public the highest-yielding CDs in the land.
Via Talk Markets · April 15, 2024
![](/next-assets/images/schema-image-default.png)
Via Benzinga · March 4, 2024
![](https://cdn.benzinga.com/files/images/story/2023/dividend_image_3.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 3, 2023
![](/next-assets/images/schema-image-default.png)
Via Benzinga · August 14, 2023
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
NEWT stock results show that NewtekOne missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • NIO (NYSENIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024
![](/next-assets/images/schema-image-default.png)
Via Benzinga · June 20, 2023
![](https://investorplace.com/wp-content/uploads/2019/07/bank-stocks.jpg)
Navigate the banking shift, with these three bank stocks likely to erode shareholder value further amidst an uncertain environment.
Via InvestorPlace · February 20, 2024
![](https://investorplace.com/wp-content/uploads/2020/10/bank-stocks-1600.jpg)
Amidst a shaky financial landscape, these are the three bank stocks to avoid in January, reflecting market volatility.
Via InvestorPlace · January 4, 2024
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-red-down-bearish-hands-1600.jpg)
Understand the risks of underperforming bank stocks in amidst the uncertainty in the market at this time offering little upside
Via InvestorPlace · December 2, 2023
![](/next-assets/images/schema-image-default.png)
Via Benzinga · October 26, 2023
![](https://investorplace.com/wp-content/uploads/2023/03/stocks-red-down-bearish-hands-1600.jpg)
Although not every financial institution is destined for the dumpsters, these worst bank stocks should probably be avoided.
Via InvestorPlace · July 13, 2023
![](/next-assets/images/schema-image-default.png)
Via Benzinga · May 19, 2023
![](https://cdn.benzinga.com/files/images/story/2023/02/28/image31.jpeg?width=1200&height=800&fit=crop)
Gainers Cardio Diagnostics Holdings, Inc. (NASDAQCDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.
Via Benzinga · February 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/02/28/image_7.jpg?width=1200&height=800&fit=crop)
Gainers Catalyst Biosciences Inc (NASDAQCBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire 3 programs related to the orphan hematology disorders.
Via Benzinga · February 28, 2023
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-federal-hall.jpg)
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Monday!
Via InvestorPlace · February 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/02/28/image-workday.png?width=1200&height=800&fit=crop)
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. AdaptHealth Corp (NASDAQAHCO) shares dipped 18.3% to $17.95 in pre-market trading after the company posted a loss for the fourth quarter.
Via Benzinga · February 28, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_130.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Kosmos Energy (NYSEKOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.
Via Benzinga · February 27, 2023